Akero Therapeutics, Inc. (AKRO) [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Dec-31-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-Q	8-K	10-Q	10-Q	10-K	10-Q	10-Q
Net income	-31.1	-25.8	-23.1	-27.4	-26.0	-32.4	-24.3	-28.9
Depreciation and amortization [+]	0.0	0.0		0.0	0.0	0.0	0.0	0.0
Depreciation	0.0	0.0		0.0	0.0	0.0	0.0	0.0
Stock-based compensation	4.8	4.8		4.2	3.3	2.6	2.6	2.4
Change in working capital [+]	5.2	-2.7		3.7	-0.3	2.6	6.8	6.3
Other current assets	0.1	-0.5		-0.6	2.7	1.1	-0.4	-0.1
Accounts payable	2.9	-0.6		2.4	-2.2	-0.2	4.6	-2.3
Accrued expenses	2.2	-1.9		1.9	-0.8	1.7	2.6	8.6
Other		0.3
Other operating activities	-1.3	-1.0		0.1	0.1	0.5	0.3	0.2
Cash from operations	-22.4	-24.6		-19.5	-22.9	-26.7	-14.6	-20.0

Capital expenditures	0.0	0.0		0.0	0.0	0.0	0.0	0.0
Purchases of short-term investments, net	-128.3	17.6		11.9	22.8	12.0	21.9	-10.7
Purchases of short-term investments	-188.8	-24.9					-11.9	-31.7
Sales of short-term investments	60.5	42.5		11.9	22.8	12.0	33.8	21.0
Cash from investing	-128.3	17.6		11.9	22.8	12.0	21.9	-10.7

Issuance of common stock, net	924.7
Option exercises	1.6	0.5			0.1	0.1	0.2	0.4
Financing costs	0.0	0.0
Other cash from financing	-586.3	15.6		34.9	0.3	0.4	0.3	0.7
Cash from financing	336.9	15.2		34.9	0.1	0.2	0.1	0.3

Free cash flow	-22.4	-24.6		-19.5	-22.9	-26.7	-14.6	-20.0
Per share (diluted)	($0.43)	($0.52)		($0.55)	($0.65)	($0.77)	($0.42)	($0.58)

Cash paid for interest	0.7	0.3